Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CETP | P11597 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | UBE2N | P61088 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18186119 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL1684856 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL18186116 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10953052 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL18186123 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL2469206 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL18186114 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL337550 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL20856812 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL18186125 | 1.00 | SPHK1 (0.64) | SPHK1CYP2D6LMNAGMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110396450-A | Multifunctional branched polymers with improved low temperature properties | AFTON CHEMICAL CORP | 2019-11-01 | — | — | CN | claimed |
| CN-105997541-A | Cosmetic composition comprising surfactant and solid fatty alcohol, and cosmetic treatment process | 莱雅公司 | 2016-10-12 | — | — | CN | claimed |
| EP-2310376-B1 | HIGH FLOW SUPRAMOLECULAR COMPOUNDS | SUPRAPOLIX BV (NL) | 2014-11-05 | — | — | EP | claimed |
| CN-101617998-B | Cosmetic or dermatological composition comprising a compound capable of creating hydrogen bonds, and cosmetic treatment method | OREAL FR | 2014-06-25 | — | — | CN | claimed |
| US-8754213-B2 | High flow supramolecular compounds | SUPRAPOLIX B.V. (NL) | 2014-06-17 | — | — | US | claimed |
| CN-103619312-A | Cosmetic composition comprising an anionic surfactant, a nonionic or amphoteric surfactant and a solid fatty alcohol and cosmetic treatment method | OREAL | 2014-03-05 | — | — | CN | claimed |
| CN-101773452-B | Structured lotions | JOHNSON & JOHNSON COMPANIES INC | 2014-02-12 | — | — | CN | claimed |
| CN-103391765-A | Cosmetic composition comprising an oil and a polymer both bearing a hydrogen-bond-generating joining group, and cosmetic treatment process | OREAL | 2013-11-13 | — | — | CN | claimed |
| WO-2013092692-A2 | COSMETIC COMPOSITION COMPRISING A HYDROPHOBICALLY MODIFIED CELLULOSE, A CATIONIC SURFACTANT AND A BRANCHED FATTY ALCOHOL | L'OREAL (FR) | 2013-06-27 | — | — | WO | claimed |
| WO-2013092608-A2 | COSMETIC COMPOSITION COMPRISING A HYDROPHOBICALLY MODIFIED CELLULOSE, A SULFATED OR SULFONATED ANIONIC SURFACTANT AND A BRANCHED FATTY ALCOHOL | L'OREAL (FR) | 2013-06-27 | — | — | WO | claimed |
| CN-103153276-A | Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and a particular oil | OREAL | 2013-06-12 | — | — | CN | claimed |
| US-20110229724-A1 | HIGH FLOW SUPRAMOLECULAR COMPOUNDS | SUPRAPOLIX B.V. | 2011-09-22 | — | — | US | claimed |
| EP-2310376-A1 | HIGH FLOW SUPRAMOLECULAR COMPOUNDS | SupraPolix B.V. (NL) | 2011-04-20 | — | — | EP | claimed |
| US-20100261628-A1 | ESTERS COMPRISING BRANCHED ALKYL GROUPS AS LUBRICANTS | COGNIS IP MANAGEMENT GMBH (DE) | 2010-10-14 | — | — | US | claimed |
| WO-2010002262-A1 | HIGH FLOW SUPRAMOLECULAR COMPOUNDS | SUPRAPOLIX B.V. (NL) | 2010-01-07 | — | — | WO | claimed |
| CN-101617998-A | Cosmetic or dermatological composition comprising a compound capable of creating hydrogen bonds, and cosmetic treatment method | OREAL | 2010-01-06 | — | — | CN | claimed |
| CN-113195446-B | Lubricating oil base oil for hydrodynamic bearing | 新日本理化株式会社 | 2024-05-31 | — | — | CN | disclosed |
| EP-4025624-A1 | MODIFIED PHENOL POLYMER AND USE THEREOF | SI Group, Inc. (US) | 2022-07-13 | — | — | EP | disclosed |
| US-6388042-B1 | POLYSILOXANES | SILTECH LLC | 2002-05-14 | — | — | US | disclosed |
| US-4655961-A | LIQUID BRANCHED ALCOHOL, HARD PARAFFIN, HYDROPHOBIC SILICA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229724-A1 | HIGH FLOW SUPRAMOLECULAR COMPOUNDS | ANXA5, HLA-B, ICAM1 | SPHK1 4075/4885CYP2D6 4456/4885LMNA 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.